Copyright
©The Author(s) 2017.
World J Clin Oncol. Oct 10, 2017; 8(5): 412-419
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.412
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.412
Figure 1 Flowchart of surgical treatment.
TME: Total mesorectal excision; LPLN: Lateral pelvic lymph node.
Figure 2 Comparative overall survival rates of patients with total mesorectal excision and lateral pelvic lymph node dissection groups.
TME: Total mesorectal excision; LPLND: Lateral pelvic lymph node dissection.
Figure 3 Comparative cumulative local recurrence rates of patients with total mesorectal excision and lateral pelvic lymph node dissection groups.
TME: Total mesorectal excision; LPLND: Lateral pelvic lymph node dissection.
- Citation: Tamura H, Shimada Y, Kameyama H, Yagi R, Tajima Y, Okamura T, Nakano M, Nakano M, Nagahashi M, Sakata J, Kobayashi T, Kosugi SI, Nogami H, Maruyama S, Takii Y, Wakai T. Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer. World J Clin Oncol 2017; 8(5): 412-419
- URL: https://www.wjgnet.com/2218-4333/full/v8/i5/412.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i5.412